Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,566.00    -24.00 (-0.52%)
Bid:
4,592.00
Ask:
4,596.00
Spread: 4.00 (0.087%)
Market Cap: £16.64b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

TRADING UPDATE

7 Jul 2023 07:00

RNS Number : 3262F
Coca-Cola HBC AG
07 July 2023
Β 

Β 

FOR IMMEDIATE RELEASE

Β 

TRADING UPDATE

Β 

COCA-COLA HBC UPGRADES PROFIT EXPECTATIONS AFTER STRONG PERFORMANCE IN FIRST SIX MONTHS OF THE YEAR

Β 

Zug, Switzerland - 7 July 2023 - Coca-Cola HBC AG ("Coca-Cola HBC") announces that, after a stronger than anticipated finish to the first six months of the year, it is upgrading its 2023 earnings expectations.

Β 

Performance in June, one of our most significant months, was very good overall. As a result, we now expect to deliver strong organic EBIT growth in the first half, led by operating leverage from double-digit top line growth, reflecting good improvements to price / mix.

Β 

As a result, we now expect organic EBIT growth for 2023 of 9-12% (previously the top end of a -3 to +3% range).

Β 

Our mid-term guidance from 2024 onwards is unchanged. We expect average annual organic revenue growth of 6-7% and average annual organic EBIT margin expansion of 20-40 basis points per annum.

Β 

The half-year 2023 results will be published on 9 August at 7:00 am BST.

Β 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the EU Market Abuse Regulation.

Β 

Enquiries

Coca‑Cola HBC Group

Investor and Analysts:

Β 

John DawsonΒ 

Head of Investor Relations

Tel: +44 7522 619509

Β john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

Virginia Phillips

Investor Relations Manager

Β 

Tel: +44 (0) 7864 686582

virginia.phillips@cchellenic.com

Β 

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Ciara Cashen

Senior Group Communications Manager

Β +353 861940885

ciara.cashen@cchellenic.com

Β 

Β 

Β 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate, and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa Coffee, Valser, RΓΆmerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTRRMATMTIMMJJ
Date   Source Headline
20th Sep 20245:21 pmRNSTransaction in Own Shares
19th Sep 20245:04 pmRNSTransaction in Own Shares
19th Sep 20242:43 pmRNSDirector/PDMR Shareholding
18th Sep 20245:13 pmRNSTransaction in Own Shares
18th Sep 20242:40 pmRNSDirector/PDMR Shareholding
18th Sep 20247:15 amRNSTransaction in Own Shares
17th Sep 20248:01 amRNSReplacement - Composition of the Board Committees
17th Sep 20247:15 amRNSTransaction in Own Shares
16th Sep 20245:05 pmRNSComposition of the Committees of the Board
16th Sep 20244:59 pmRNSResult of Extraordinary General Meeting
11th Sep 20246:11 pmRNSTransaction in Own Shares
4th Sep 20249:37 amRNSDirector/PDMR Shareholding
4th Sep 20249:30 amRNSReplacement - Transaction in Own Shares
3rd Sep 20245:42 pmRNSTransaction in Own Shares
3rd Sep 202412:41 pmRNSDirector/PDMR Shareholding
2nd Sep 202412:20 pmRNSAthens Exchange trading date of ordinary shares
2nd Sep 202410:01 amRNSDirector/PDMR Shareholding
2nd Sep 20249:53 amRNSDirector/PDMR Shareholding
2nd Sep 20248:44 amRNSTotal Voting Rights
30th Aug 20249:21 amRNSParticipating in Barclays Conference
29th Aug 20245:01 pmRNSTransaction in Own Shares
28th Aug 20245:09 pmRNSTransaction in Own Shares
27th Aug 20245:06 pmRNSTransaction in Own Shares
23rd Aug 20245:24 pmRNSTransaction in Own Shares
23rd Aug 20248:32 amRNSNotice of EGM
22nd Aug 20245:18 pmRNSTransaction in Own Shares
21st Aug 20245:08 pmRNSTransaction in Own Shares
21st Aug 20247:10 amRNSTransaction in Own Shares
19th Aug 20245:22 pmRNSTransaction in Own Shares
19th Aug 20241:06 pmRNSDirector/PDMR Shareholding
19th Aug 20247:53 amRNSTransaction in Own Shares
16th Aug 20247:15 amRNSTransaction in Own Shares
14th Aug 20245:16 pmRNSTransaction in Own Shares
13th Aug 20245:11 pmRNSTransaction in Own Shares
12th Aug 20245:28 pmRNSTransaction in Own Shares
9th Aug 20245:22 pmRNSTransaction in Own Shares
9th Aug 202410:14 amRNSresignation of director Anna Diamantopoulou
8th Aug 20245:12 pmRNSTransaction in Own Shares
7th Aug 20247:00 amRNSStrong growth and share gains
1st Aug 202410:53 amRNSTransfer of treasuryshares and total voting rights
18th Jul 20242:33 pmRNSDirector/PDMR Shareholding
15th Jul 202412:39 pmRNSNotice of Results
1st Jul 20244:59 pmRNSTransfer of treasuryshares and total voting rights
28th Jun 20245:18 pmRNSTransaction in Own Shares
28th Jun 20241:46 pmRNSDirector/PDMR Shareholding
27th Jun 20245:08 pmRNSTransaction in Own Shares
26th Jun 20245:27 pmRNSTransaction in Own Shares
25th Jun 20245:17 pmRNSTransaction in Own Shares
24th Jun 20245:18 pmRNSTransaction in Own Shares
21st Jun 20245:11 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.